Novel inhibitors | DC Chemicals

Cat. No.	Product name	CAS No.
DCC4042	Pd-128907 Hydrochloride Selective D3 dopamine receptor agonist	123594-64-9
DCC4043	Pd-151242 Selective antagonist for human ETA receptors	155561-67-4
DCC4044	Pd160170 Neuropeptide Y Y1 receptor antagonist	181468-88-2
DCC4045	Pd-160725 Isethionate AMPA receptor antagonist	1262769-92-5
DCC4046	Pd-161989 Isethionate AMPA receptor antagonist	1262770-05-7
DCC4047	Pd-174494 Novel, potent, and selective NR1/2B NMDA receptor antagonist	193359-26-1
DCC4048	P-d1ago Novel cell specific photoswitchable agonist for reversible control of endogenous dopamine receptors
DCC4049	Pd26-tl07 Novel selective inhibitor of STAT3 phosphorylation, binding to the SH2 domain of STAT3, exhibiting remarkable antiproliferative activity against three cancer cell lines (HCT-116, SW480 and MDA-MB-231)
DCC4050	pda-66 Novel inducer of mitotic arrest and apoptosis in human progenitor and cancer cells	1613633-78-5
DCC4051	Pdd4091 Novel G6PD inhibitor
DCC4052	Pde5-in-42 Potent and selective second-generation phosphodiesterase type 5 (PDE5) inhibitor	936449-28-4
DCC4053	Pde7 Inhibitor S14 Novel cell-permeable PDE7 inhibitor, targeting the cyclic adenosine monophosphate (cAMP)/cAMP-response element binding protein (CREB) pathway, exerting neuroprotection in an Alzheimer's disease (AD) model	18741-24-7
DCC4054	Pde9-in-16 Novel selective PDE9 inhibitor with strong antioxidant activity, inhibiting Aβ aggregation as potential candidates for the treatment of Alzheimer’s disease
DCC4055	Pde9-in-2 Novel Potent, Selective, and Orally Bioavailable Inhibitor against Phosphodiesterase-9 (PDE9)
DCC4056	P-decylaminophenol Novel inhibitor of melanogenesis	23227-12-5
DCC4057	Pdf Inhibitor M-2 Novel Peptide Deformylase (PDF) Inhibitor
DCC4058	Pdi-in-p1 Protein disulfide isomerase (PDI) inhibitor	1461648-55-4
DCC4059	Pd-l1 Degrader F4 Novel PD-L1 degrader, showing 66.99% degradation activity at 20 μM with no calcium blocking effect, strengthening the T cell-mediated killing of tumor cells
DCC4060	Pd-l1 Degrader P22 Novel PROTAC dual inhibitor and degrader of PD-L1, inhibiting PD-1/PD-L1 interaction with IC50 of 39.2 nM in an HTRF binding assay	2447066-37-5
DCC4061	Pd-l1 Inhibitor L7 Novel Potent PD-L1 Inhibitor (IC50 1.8 nM), binding to human PD-L1 (hPD-L1) with a KD value of 3.34 nM, without showing any binding to hPD-1, blocking PD-1/PD-L1 interaction with an EC50 value of 375 nM
DCC4062	Pdsinh-c01 Novel pendrin inhibitor, inhibiting Cl-/anion exchange mediated by mouse pendrin without affecting other major kidney tubule transporters
DCC4063	Peg-vtx Novel polyethylene glycol (PEG)-drug conjugate of Venetoclax, a Bcl-2 inhibitor, for treatment of acute myeloid leukemia (AML)